Tesla HODLs Bitcoin — But Sticks To Dogecoin-Only Crypto Payments Policy
Electric car maker Tesla Inc (NASDAQ: TLSA) continues to hold on to Bitcoin (CRYPTO: BTC) but only accepts Dogecoin (CRYPTO:
Tiziana Life Sciences Posts Additional Clinical Improvements In Second Patient with Multiple Sclerosis
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that the second patient (EA2) with non-active secondary progressive multiple sclerosis (SPMS) receiving…
Tiziana Life Sciences Announces Additional Clinical Improvements In The Second Patient With Non-Active Secondary Progressive Multiple Sclerosis After Eleven Months Of Dosing With Intranasal Foralumab
Tiziana Life Sciences Ltd. (NASDAQ:TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today
Tiziana Life Sciences Announces Near-Term Strategic Focus On Intranasal Foralumab For Diseases Of The Central Nervous System
Tiziana Life Sciences Ltd. (NASDAQ:TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced
Tiziana Life Sciences Plans To Submit IND For Phase 1 Trial Of Intranasal Foralumab In Alzheimer’s Disease Patients
Tiziana Life Sciences Ltd. (NASDAQ: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announcedTiziana Life Sciences Ltd.
Tiziana Life Sciences Announced Presentations on Intranasal Foralumab at the “Preserving the Brain” Scientific Conference and Exhibit at the Fondazione Prada in Milan
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) today announced that poster presentations on intranasal foralumab were presented at the "Preserving the Brain" scientific conference and exhibit held at the Fondazione Prada in Milan, Italy.
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers
Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers
Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday’s Mid-Day Session
Gainers
MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Tiziana Life Sciences Announces Grant Received By The Brigham And Women’s Hospital To Explore The Use Of Intranasal anti-CD3 mAb In Amyotrophic Lateral Sclerosis
Tiziana Life Sciences Ltd.(NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces that